<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xml:lang="en" article-type="rapid-communication" dtd-version="2.3">
  <front>
    <journal-meta>
      <journal-id journal-id-type="publisher-id">molbank</journal-id>
      <journal-title>Molbank</journal-title>
      <abbrev-journal-title abbrev-type="publisher">Molbank</abbrev-journal-title>
      <abbrev-journal-title abbrev-type="pubmed">Molbank</abbrev-journal-title>
      <issn pub-type="epub">1422-8599</issn>
      <publisher>
        <publisher-name>MDPI</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="doi">10.3390/M705</article-id>
      <article-id pub-id-type="publisher-id">molbank-2010-M705</article-id>
      <article-categories>
        <subj-group>
          <subject>Short Note</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title><italic>N,N'</italic>-1,2-Phenylenebis[4-(chloromethyl)benzamide]</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Bachl</surname>
            <given-names>J&#xFC;rgen</given-names>
          </name>
          <xref rid="af1-molbank-2010-M705" ref-type="aff">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>D&#xED;az</surname>
            <given-names>David D.</given-names>
          </name>
          <xref rid="af1-molbank-2010-M705" ref-type="aff">1</xref>
          <xref rid="af2-molbank-2010-M705" ref-type="aff">2</xref>
          <xref rid="c1-molbank-2010-M705" ref-type="corresp">*</xref>
        </contrib>
      </contrib-group>
      <aff id="af1-molbank-2010-M705"><label>1</label>Institut f&#xFC;r Organische Chemie, Universit&#xE4;t Regensburg, Universit&#xE4;tsstr 31, 93040 Regensburg, Germany</aff>
      <aff id="af2-molbank-2010-M705"><label>2</label>ICMA, CSIC-Universidad de Zaragoza, Pedro Cerbuna 12, 50009 Zaragoza, Spain</aff>
      <author-notes>
        <corresp id="c1-molbank-2010-M705"><label>*</label>Author to whom correspondence should be addressed; E-Mail: <email>David.Diaz@chemie.uni-regensburg.de</email>.</corresp>
      </author-notes>
      <pub-date pub-type="epub">
        <day>04</day>
        <month>11</month>
        <year>2010</year>
      </pub-date>
      <pub-date pub-type="collection">
        <month>12</month>
        <year>2010</year>
      </pub-date>
      <volume>2010</volume>
      <issue>4</issue>
      <elocation-id>M705</elocation-id>
      <history>
        <date date-type="received">
          <day>08</day>
          <month>10</month>
          <year>2010</year>
        </date>
        <date date-type="accepted">
          <day>01</day>
          <month>11</month>
          <year>2010</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9; 2010 by the authors; licensee MDPI, Basel, Switzerland.</copyright-statement>
        <copyright-year>2010</copyright-year>
        <license>
          <p>This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/3.0/).</p>
        </license>
      </permissions>
      <abstract>
        <p><italic>N,N'</italic>-1,2-Phenylenebis[4-(chloromethyl)benzamide] (<bold>3</bold>) was obtained in 61% yield by nucleophilic acyl substitution of 4-(chloromethyl)benzoyl chloride (<bold>2</bold>) with 1,2-phenylenediamine (<bold>1</bold>) under basic conditions. The title compound was characterized by FT-IR, <sup>1</sup>H NMR, <sup>13</sup>C NMR, low- and high-resolution EI-MS, and melting point.</p>
      </abstract>
      <kwd-group>
        <kwd><italic>o</italic>-phenylenediamine</kwd>
        <kwd>benzamide</kwd>
        <kwd>nucleophilic acyl substitution</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
      <p>Substituted benzamides have been in clinical use for many years as anti-emetics, anti-arrhythmics, neuroleptics, and/or anti-psychotics in the treatment of various disorders [<xref ref-type="bibr" rid="B1-molbank-2010-M705">1</xref>]. They also constitute versatile intermediates for the synthesis of anti-tumor and anti-inflammatory agents [<xref ref-type="bibr" rid="B2-molbank-2010-M705">2</xref>], protease inhibitors [<xref ref-type="bibr" rid="B3-molbank-2010-M705">3</xref>], dyes [<xref ref-type="bibr" rid="B4-molbank-2010-M705">4</xref>], and have been extensively used as sensitizers for radio- or chemotherapies [<xref ref-type="bibr" rid="B5-molbank-2010-M705">5</xref>]. On the other hand, benzyl chloride derivatives are widely used as synthetic building blocks. They constitute, for instance, the precursors to benzyl esters, which are commonly employed in industry as plasticizers, flavorants, and perfumes [<xref ref-type="bibr" rid="B6-molbank-2010-M705">6</xref>]. Hence, organic molecules bearing both functionalities may be of practical interest.</p>
      <p>We report here the synthesis of <italic>N,N'</italic>-1,2-phenylenebis[4-(chloromethyl)benzamide] (<bold>3</bold>) by nucleophilic acyl substitution of 4-(chloromethyl)benzoyl chloride (<bold>2</bold>) with 1,2-phenylenediamine (<bold>1</bold>) in the presence of Et<sub>3</sub>N (<xref ref-type="scheme" rid="molbank-2010-M705-sch001">Scheme 1</xref>) [<xref ref-type="bibr" rid="B7-molbank-2010-M705">7</xref>].</p>
    <sec>
      <title>Experimental Section</title>
      <sec>
        <title>General</title>
        <p><sup>1</sup>H and <sup>13</sup>C NMR spectra were recorded at 25 &#xB0;C on a Bruker 400 spectrometer in DMSO-<italic>d</italic><sub>6</sub> as solvent, and chemical shifts are reported relative to residual solvent peaks [<xref ref-type="bibr" rid="B8-molbank-2010-M705">8</xref>]. The low-resolution mass spectrum was obtained using a Varian MAT 311A spectrometer. The infrared spectrum was recorded using a Diamond ATR (attenuated total reflection) accessory (Golden Gate) on a Bio-Rad Excalibur FTS 3000 MX spectrophotometer. The melting point (mp) was measured in an Opti Melt MPA 100 instrument and is uncorrected. Thin-layer chromatography was carried out on Merck aluminium sheets coated with silica gel 60 F<sub>254</sub>. Compounds were visualized by use of 254 nm UV light and/or phosphomolybdic acid 20% (wt.) solution in ethanol with heating. All solvents were of p.a. grade or were purified by standard techniques [<xref ref-type="bibr" rid="B9-molbank-2010-M705">9</xref>]. Anhydrous sodium sulfate was used for drying solutions. 1,2-Phenylenediamine (<bold>1</bold>) and 4-(chloromethyl)benzoyl chloride (<bold>2</bold>) were purchased from commercial suppliers and used as received without further purification.</p>
      </sec>
      <sec>
        <title>Synthesis of N,N'-1,2-phenylenebis[4-(chloromethyl)benzamide] (<bold>3</bold>)</title>
        <p>To a stirred solution of 1,2-phenylenediamine (<bold>1</bold>) (500 mg, 4.55 mmol) and Et<sub>3</sub>N (1.59 mL, 11.4 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (20 mL) kept at 0 &#xB0;C was added dropwise (using a pressure-compensated addition funnel) a solution of 4-(chloromethyl)benzoyl chloride (<bold>2</bold>) (1.75 g, 9.09 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (20 mL). The reaction mixture was allowed to stir for 5 h at room temperature, after which time TLC analysis showed full conversion of the starting materials. The organic phase was washed with H<sub>2</sub>O (15 mL &#xD7; 2) and brine (15 mL &#xD7; 2), dried (Na<sub>2</sub>SO<sub>4</sub>), filtered, and concentrated. The solid residue was recrystallized from CH<sub>2</sub>Cl<sub>2</sub>/pentane, affording product <bold>3</bold> (1.1 g, 61% yield [<xref ref-type="bibr" rid="B10-molbank-2010-M705">10</xref>]) as a white crystalline solid: TLC <italic>R</italic><sub>f</sub> (AcOEt/hexane 1:1) 0.40; mp = 191&#x2013;193 &#xB0;C; <sup>1</sup>H NMR (400 MHz, DMSO-<italic>d</italic><sub>6</sub>) &#x3B4;/ppm = 4.83 (s, 4H), 7.31 (dd, <italic>J</italic> = 6.0, 3.6 Hz, 2H), 7.59 (d, <italic>J</italic> = 8.4 Hz, 4H), 7.67 (dd, <italic>J</italic> = 6.0, 3.6 Hz, 2H), 7.96 (d, <italic>J</italic> = 8.4 Hz, 4H), 10.08 (s, 2H); <sup>13</sup>C NMR (100 MHz, DMSO-<italic>d</italic><sub>6</sub>) &#x3B4;/ppm = 45.23 (2C), 125.51 (2C), 125.80 (2C), 127.81 (4C), 128.83 (4C), 131.19 (2C), 133.97 (2C), 141.22 (2C), 164.92 (2C); FT-IR (ATR) &#x3BD;<sub>max</sub> (cm<sup>&#x2212;1</sup>) 3287 (N-H stretching), 1644 (C=O stretching, amide I band), 1514 (N-H bending, amide II band), 1305, 1267 (C-H stretching, CH<sub>2</sub>Cl), 672, 476; MS (ESI) <italic>m/z</italic> 412 [M<sup>+</sup>]. HRMS calculated for C<sub>22</sub>H<sub>18</sub>Cl<sub>2</sub>N<sub>2</sub>O<sub>2</sub> 412.07453; found 412.07426.</p>
      </sec>
    </sec>
  </body>
  <back>
  <app-group>
    <app id="app1-molbank-2010-M705">
        <title>Supplementary materials</title>
        <supplementary-material id="molbank-2010-M705-s001" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="molbank-2010-M705-s001-mod.mol">
   <label>Supplementary File 1</label>
</supplementary-material>
        <supplementary-material id="molbank-2010-M705-s002" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="molbank-2010-M705-s001.mol">
   <label>Supplementary File 2</label>
</supplementary-material>
        <supplementary-material id="molbank-2010-M705-s003" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="molbank-2010-M705-s002.doc">
   <label>Supplementary File 3</label>
</supplementary-material>
    </app>
</app-group>
    <ack>
      <title>Acknowledgements</title>
      <p>D.D.D. thanks the Alexander von Humboldt Foundation for a research fellowship for experienced researchers.</p>
    </ack>
    <ref-list>
      <title>References and Notes</title>
      <ref id="B1-molbank-2010-M705">
        <label>1.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Norman</surname>
              <given-names>M.H.</given-names>
            </name>
            <name>
              <surname>Rigdon</surname>
              <given-names>G.C.</given-names>
            </name>
            <name>
              <surname>Hall</surname>
              <given-names>W.R.</given-names>
            </name>
            <name>
              <surname>Navas</surname>
              <given-names>F.</given-names>
            </name>
          </person-group>
          <article-title>Structure-activity relationships of a series of substituted benzamides: Potent D2/5-HT2 antagonists and 5-HT1a agonists as neuroleptic agents</article-title>
          <source>J. Med. Chem.</source>
          <year>1996</year>
          <volume>39</volume>
          <fpage>1172</fpage>
          <lpage>1188</lpage>
          <pub-id pub-id-type="doi">10.1021/jm950551d</pub-id>
          <pub-id pub-id-type="pmid">8676355</pub-id>
        </citation>
      </ref>
      <ref id="B2-molbank-2010-M705">
        <label>2.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Liberg</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Lazarevic</surname>
              <given-names>B.</given-names>
            </name>
            <name>
              <surname>Pero</surname>
              <given-names>R.W.</given-names>
            </name>
            <name>
              <surname>Leanderson</surname>
              <given-names>T.</given-names>
            </name>
          </person-group>
          <article-title><italic>N</italic>-substituted benzamides inhibit NF&#x3BA;B activation and induce apoptosis by separate mechanisms</article-title>
          <source>Br. J. Cancer</source>
          <year>1999</year>
          <volume>81</volume>
          <fpage>981</fpage>
          <lpage>988</lpage>
          <pub-id pub-id-type="doi">10.1038/sj.bjc.6690796</pub-id>
          <pub-id pub-id-type="pmid">10576654</pub-id>
        </citation>
      </ref>
      <ref id="B3-molbank-2010-M705">
        <label>3.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Reich</surname>
              <given-names>S.H.</given-names>
            </name>
            <name>
              <surname>Johnson</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Wallace</surname>
              <given-names>M.B.</given-names>
            </name>
            <name>
              <surname>Kephart</surname>
              <given-names>S.E.</given-names>
            </name>
            <name>
              <surname>Fuhrman</surname>
              <given-names>S.A.</given-names>
            </name>
            <name>
              <surname>Worland</surname>
              <given-names>S.T.</given-names>
            </name>
            <name>
              <surname>Matthews</surname>
              <given-names>D.A.</given-names>
            </name>
            <name>
              <surname>Hendrickson</surname>
              <given-names>T.F.</given-names>
            </name>
            <name>
              <surname>Chan</surname>
              <given-names>F.</given-names>
            </name>
            <name>
              <surname>Meador</surname>
              <given-names>J.</given-names>
			  <suffix>III</suffix>
            </name>
            <name>
              <surname>Ferre</surname>
              <given-names>R.A.</given-names>
            </name>
            <name>
              <surname>Brown</surname>
              <given-names>E.L.</given-names>
            </name>
            <name>
              <surname>DeLisle</surname>
              <given-names>D.M.</given-names>
            </name>
            <name>
              <surname>Patick</surname>
              <given-names>A.K.</given-names>
            </name>
            <name>
              <surname>Binford</surname>
              <given-names>S.L.</given-names>
            </name>
            <name>
              <surname>Ford</surname>
              <given-names>C.E.</given-names>
            </name>
          </person-group>
          <article-title>Substituted Benzamide Inhibitors of Human Rhinovirus 3C Protease: Structure-Based Design, Synthesis, and Biological Evaluation</article-title>
          <source>J. Med. Chem.</source>
          <year>2000</year>
          <volume>43</volume>
          <fpage>1670</fpage>
          <lpage>1683</lpage>
          <pub-id pub-id-type="doi">10.1021/jm9903242</pub-id>
          <pub-id pub-id-type="pmid">10794684</pub-id>
        </citation>
      </ref>
      <ref id="B4-molbank-2010-M705">
        <label>4.</label>
        <citation citation-type="book">
          <person-group person-group-type="author">
            <name>
              <surname>Zollinger</surname>
              <given-names>H.</given-names>
            </name>
          </person-group>
          <source>Color Chemistry: Syntheses, Properties and Applications of Organic Dyes and Pigments</source>
          <edition>3rd ed.</edition>
          <publisher-name>Wiley-VCH</publisher-name>
          <publisher-loc>Weinheim, Germany</publisher-loc>
          <year>2003</year>
        </citation>
      </ref>
      <ref id="B5-molbank-2010-M705">
        <label>5.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Pero</surname>
              <given-names>R.W.</given-names>
            </name>
            <name>
              <surname>Olsson</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Amiri</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Chaplin</surname>
              <given-names>D.</given-names>
            </name>
          </person-group>
          <article-title>Multiple mechanisms of action of the benzamides and nicotinamides as sensitizers of radiotherapy: Opportunities for drug design</article-title>
          <source>Cancer Detect. Prev.</source>
          <year>1998</year>
          <volume>22</volume>
          <fpage>225</fpage>
          <lpage>236</lpage>
          <pub-id pub-id-type="doi">10.1046/j.1525-1500.1998.0OA30.x</pub-id>
          <pub-id pub-id-type="pmid">9618044</pub-id>
        </citation>
      </ref>
      <ref id="B6-molbank-2010-M705">
        <label>6.</label>
        <citation citation-type="book">
          <person-group person-group-type="author">
            <name>
              <surname>Rossberg</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Lendle</surname>
              <given-names>W.</given-names>
            </name>
            <name>
              <surname>Pfleiderer</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>T&#xF6;gel</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Dreher</surname>
              <given-names>E.-L.</given-names>
            </name>
            <name>
              <surname>Langer</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Rassaerts</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Kleinschmidt</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Strack</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Cook</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Beck</surname>
              <given-names>U.</given-names>
            </name>
            <name>
              <surname>Lipper</surname>
              <given-names>K.-A.</given-names>
            </name>
            <name>
              <surname>Torkelson</surname>
              <given-names>T.R.</given-names>
            </name>
            <name>
              <surname>L&#xF6;ser</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Beutel</surname>
              <given-names>K.K.</given-names>
            </name>
            <name>
              <surname>Mann</surname>
              <given-names>T.</given-names>
            </name>
          </person-group>
          <article-title>Chlorinated Hydrocarbons</article-title>
          <source>Ullmann&#x2019;s Encyclopedia of Industrial Chemistry</source>
          <publisher-name>Wiley-VCH</publisher-name>
          <publisher-loc>Weinheim, Germany</publisher-loc>
          <year>2006</year>
        </citation>
      </ref>
      <ref id="B7-molbank-2010-M705">
        <label>7.</label>
        <note><p>For the synthesis of the linear analogues using <italic>p</italic>-phenylenediamine, see: 
		<citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Misawa</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Koumura</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>Matsumoto</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Tamaoki</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>Yoshida</surname>
              <given-names>M.</given-names>
            </name>
          </person-group>
          <article-title>Hydrogels Based on Surfactant-Free Ionene Polymers with <italic>N,N</italic>&#x2B9;&#x2032;-(<italic>p</italic>-Phenylene)dibenzamide Linkages</article-title>
          <source>Macromolecules</source>
          <year>2008</year>
          <volume>41</volume>
          <fpage>8841</fpage>
          <lpage>8846</lpage>
        </citation></p></note>
      </ref>
      <ref id="B8-molbank-2010-M705">
        <label>8.</label>
		<note><p>See <xref ref-type="app" rid="app1-molbank-2010-M705">Supplementary Files</xref>.</p></note>
      </ref>
      <ref id="B9-molbank-2010-M705">
        <label>9.</label>
        <citation citation-type="book">
          <person-group person-group-type="author">
            <name>
              <surname>Armarego</surname>
              <given-names>W.L.F.</given-names>
            </name>
            <name>
              <surname>Perrin</surname>
              <given-names>D.D.</given-names>
            </name>
          </person-group>
          <source>Purification of Laboratory Chemicals</source>
          <edition>4th ed.</edition>
          <publisher-name>Butterworth-Heinemann</publisher-name>
          <publisher-loc>Oxford, UK</publisher-loc>
          <year>1996</year>
        </citation>
      </ref>
      <ref id="B10-molbank-2010-M705">
        <label>10.</label>
		<note><p>The qualitative TLC analysis of the reaction crude showed the presence of additional minor products. Unfortunately, we were unable to isolate and identify such products by column chromatography. Nevertheless, the major loss in the yield comes most likely from the recrystal¬lization, filtration and washing procedures used to purify the title compound. </p></note>
      </ref>
    </ref-list>
    <sec sec-type="display-objects">
      <title>Scheme</title>
      <fig id="molbank-2010-M705-sch001" position="float">
        <object-id pub-id-type="pii">molbank-2010-M705-sch001_Scheme 1</object-id>
        <label>Scheme 1</label>
        <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="molbank-2010-M705-sch001.tif"/>
      </fig>
    </sec>
  </back>
</article>
